Steven Perrin is President at Eledon Pharmaceuticals, Inc. (ELDN). They have made 1 open-market trade across 1 company since 2022, most recently 2026-07-31.
CIK 0001824545
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELDN | 81,215 | $173K |
Shares reported on the most recent Form 4, priced at the 2026-08-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELDN | BUY | 2022-11-23 | 2022-11-23 | $2.60 | $3K | -4.0% | -2.4% | -4.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.